Literature DB >> 17904578

Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphatase.

Eunhee Lee1, David B Hayes, Knut Langsetmo, Eric J Sundberg, Terence C Tao.   

Abstract

Nitric oxide induces vasodilation by elevating the production of cGMP, an activator of cGMP-dependent protein kinase (PKG). PKG subsequently causes smooth muscle relaxation in part via activation of myosin light chain phosphatase (MLCP). To date, the interaction between PKG and the targeting subunit of MLCP (MYPT1) is not fully understood. Earlier studies by one group of workers showed that the binding of PKG to MYPT1 is mediated by the leucine-zipper motifs at the N and C termini, respectively, of the two proteins. Another group, however, reported that binding of PKG to MYPT1 did not require the leucine-zipper motif of MYPT1. In this work we fully characterized the interaction between PKG and MYPT1 using biophysical techniques. For this purpose we constructed a recombinant PKG peptide corresponding to a predicted coiled coil region that contains the leucine-zipper motif. We further constructed various C-terminal MYPT1 peptides bearing various combinations of a predicted coiled coil region, extensions preceding this coiled coil region, and the leucine-zipper motif. Our results show, firstly, that while the leucine-zipper motif at the N terminus of PKG forms a homodimeric coiled coil, the one at the C terminus of MYPT1 is monomeric and non-helical. Secondly, the leucine-zipper motif of PKG binds to that of MYPT1 to form a heterodimer. Thirdly, when the leucine-zipper motif of MYPT1 is absent, the PKG leucine-zipper motif binds to the coiled coil region and upstream segments of MYPT1 via formation of a heterotetramer. These results provide rationalization of some of the findings by others using alternative binding analyses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904578      PMCID: PMC4310484          DOI: 10.1016/j.jmb.2007.08.049

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  40 in total

1.  Recombinant small subunit of smooth muscle myosin light chain phosphatase. Molecular properties and interactions with the targeting subunit.

Authors:  K Langsetmo; W F Stafford; K Mabuchi; T Tao
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

2.  Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium.

Authors:  M C Gong; A Fuglsang; D Alessi; S Kobayashi; P Cohen; A V Somlyo; A P Somlyo
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

3.  Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation.

Authors:  E F Etter; M Eto; R L Wardle; D L Brautigan; R A Murphy
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

Review 4.  Signal transduction and regulation in smooth muscle.

Authors:  A P Somlyo; A V Somlyo
Journal:  Nature       Date:  1994-11-17       Impact factor: 49.962

5.  Cyclic GMP-dependent protein kinase activates cloned BKCa channels expressed in mammalian cells by direct phosphorylation at serine 1072.

Authors:  M Fukao; H S Mason; F C Britton; J L Kenyon; B Horowitz; K D Keef
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

6.  Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms.

Authors:  M Eto; T Kitazawa; M Yazawa; H Mukai; Y Ono; D L Brautigan
Journal:  J Biol Chem       Date:  2001-06-07       Impact factor: 5.157

7.  Isolated regulatory domains of cGMP-dependent protein kinase Ialpha and Ibeta retain dimerization and native cGMP-binding properties and undergo isoform-specific conformational changes.

Authors:  Robyn Richie-Jannetta; Jennifer L Busch; Kristin A Higgins; Jackie D Corbin; Sharron H Francis
Journal:  J Biol Chem       Date:  2006-01-09       Impact factor: 5.157

8.  IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase.

Authors:  Angela Geiselhöringer; Matthias Werner; Katja Sigl; Petra Smital; René Wörner; Linda Acheo; Juliane Stieber; Pascal Weinmeister; Robert Feil; Susanne Feil; Jörg Wegener; Franz Hofmann; Jens Schlossmann
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

Review 9.  Myosin light chain phosphatase: subunit composition, interactions and regulation.

Authors:  D J Hartshorne; M Ito; F Erdödi
Journal:  J Muscle Res Cell Motil       Date:  1998-05       Impact factor: 2.698

10.  A novel mechanism for the Ca(2+)-sensitizing effect of protein kinase C on vascular smooth muscle: inhibition of myosin light chain phosphatase.

Authors:  M Masuo; S Reardon; M Ikebe; T Kitazawa
Journal:  J Gen Physiol       Date:  1994-08       Impact factor: 4.086

View more
  20 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  NMR insight into myosin-binding subunit coiled-coil structure reveals binding interface with protein kinase G-Iα leucine zipper in vascular function.

Authors:  Alok K Sharma; Gabriel Birrane; Clemens Anklin; Alan C Rigby; Seth L Alper
Journal:  J Biol Chem       Date:  2017-03-09       Impact factor: 5.157

3.  Crystal structure of the cGMP-dependent protein kinase II leucine zipper and Rab11b protein complex reveals molecular details of G-kinase-specific interactions.

Authors:  Albert S Reger; Matthew P Yang; Shizuyo Koide-Yoshida; Elaine Guo; Shrenik Mehta; Keizo Yuasa; Alan Liu; Darren E Casteel; Choel Kim
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.157

4.  A bioinformatic and computational study of myosin phosphatase subunit diversity.

Authors:  Rachael P Dippold; Steven A Fisher
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-04       Impact factor: 3.619

Review 5.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

6.  An N-terminally truncated form of cyclic GMP-dependent protein kinase Iα (PKG Iα) is monomeric and autoinhibited and provides a model for activation.

Authors:  Thomas M Moon; Jessica L Sheehe; Praveena Nukareddy; Lydia W Nausch; Jessica Wohlfahrt; Dwight E Matthews; Donald K Blumenthal; Wolfgang R Dostmann
Journal:  J Biol Chem       Date:  2018-03-30       Impact factor: 5.157

7.  Structures of cGMP-Dependent Protein Kinase (PKG) Iα Leucine Zippers Reveal an Interchain Disulfide Bond Important for Dimer Stability.

Authors:  Liying Qin; Albert S Reger; Elaine Guo; Matthew P Yang; Peter Zwart; Darren E Casteel; Choel Kim
Journal:  Biochemistry       Date:  2015-07-15       Impact factor: 3.162

8.  Par-4: a new activator of myosin phosphatase.

Authors:  Susanne Vetterkind; Eunhee Lee; Eric Sundberg; Ransom H Poythress; Terence C Tao; Ute Preuss; Kathleen G Morgan
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

Review 9.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

10.  Probing the interaction between the coiled coil leucine zipper of cGMP-dependent protein kinase Ialpha and the C terminus of the myosin binding subunit of the myosin light chain phosphatase.

Authors:  Alok K Sharma; Guo-Ping Zhou; Joseph Kupferman; Howard K Surks; Eva N Christensen; James J Chou; Michael E Mendelsohn; Alan C Rigby
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.